Abzena PLC (LON:ABZA)’s share price hit a new 52-week low on Monday . The company traded as low as GBX 22 ($0.30) and last traded at GBX 24 ($0.33), with a volume of 70000 shares. The stock had previously closed at GBX 24.50 ($0.34).
A number of equities analysts recently weighed in on the stock. Numis Securities reissued a “buy” rating and issued a GBX 80 ($1.11) price target on shares of Abzena in a report on Wednesday, December 13th. FinnCap reissued a “buy” rating and issued a GBX 70 ($0.97) price target on shares of Abzena in a report on Monday, December 11th. Finally, Peel Hunt reissued a “buy” rating and issued a GBX 42 ($0.58) price target on shares of Abzena in a report on Monday, March 5th.
The stock has a market capitalization of $50.91 and a price-to-earnings ratio of -300.00.
WARNING: This piece of content was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3302749/abzena-abza-reaches-new-1-year-low-at-22-00.html.
Abzena Company Profile
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena and related companies with MarketBeat.com's FREE daily email newsletter.